Viewing Study NCT05743595

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:20 PM
Ignite Modification Date: 2026-05-05 @ 11:36 AM
Study NCT ID: NCT05743595
Status: RECRUITING
Last Update Posted: 2025-12-10
First Post: 2023-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Sponsor: Washington University School of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unmethylated Glioblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None glioblastoma View
None neoantigen vaccine View
None PD-1 blockade View
None unmethylated MGMT View